FDA Approves Sunlenca for Treatment-Resistant HIV

THURSDAY, Dec. 29, 2022 -- The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other...